A detailed history of Clearstead Advisors, LLC transactions in Agilent Technologies, Inc. stock. As of the latest transaction made, Clearstead Advisors, LLC holds 420 shares of A stock, worth $53,369. This represents 0.0% of its overall portfolio holdings.

Number of Shares
420
Previous 417 0.72%
Holding current value
$53,369
Previous $54,000 14.81%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$125.42 - $148.48 $376 - $445
3 Added 0.72%
420 $62,000
Q2 2024

Aug 09, 2024

SELL
$129.63 - $154.64 $6,611 - $7,886
-51 Reduced 10.9%
417 $54,000
Q1 2024

May 14, 2024

SELL
$128.12 - $149.31 $22,164 - $25,830
-173 Reduced 26.99%
468 $68,000
Q4 2023

Feb 12, 2024

SELL
$101.17 - $139.82 $28,327 - $39,149
-280 Reduced 30.4%
641 $89,000
Q3 2023

Nov 13, 2023

SELL
$109.73 - $128.47 $27,761 - $32,502
-253 Reduced 21.55%
921 $102,000
Q3 2023

Nov 07, 2023

BUY
$109.73 - $128.47 $26,444 - $30,961
241 Added 25.83%
1,174 $131,000
Q1 2023

May 09, 2023

BUY
$131.13 - $159.06 $5,769 - $6,998
44 Added 4.95%
933 $129,000
Q3 2022

Nov 14, 2022

SELL
$115.11 - $142.29 $5,870 - $7,256
-51 Reduced 5.43%
889 $108,000
Q2 2022

Aug 12, 2022

SELL
$112.71 - $135.93 $20,513 - $24,739
-182 Reduced 16.22%
940 $112,000
Q4 2021

Feb 14, 2022

BUY
$147.95 - $164.3 $13,463 - $14,951
91 Added 8.83%
1,122 $179,000
Q3 2021

Nov 12, 2021

BUY
$147.58 - $179.28 $113,636 - $138,045
770 Added 295.02%
1,031 $162,000
Q2 2021

Aug 12, 2021

BUY
$127.69 - $148.81 $2,043 - $2,380
16 Added 6.53%
261 $39,000
Q2 2020

Aug 11, 2020

SELL
$68.92 - $91.14 $2,963 - $3,919
-43 Reduced 14.93%
245 $22,000
Q1 2020

May 14, 2020

BUY
$63.37 - $90.13 $18,250 - $25,957
288 New
288 $21,000

Others Institutions Holding A

About AGILENT TECHNOLOGIES, INC.


  • Ticker A
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 296,040,992
  • Market Cap $37.6B
  • Description
  • Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatogra...
More about A
Track This Portfolio

Track Clearstead Advisors, LLC Portfolio

Follow Clearstead Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearstead Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearstead Advisors, LLC with notifications on news.